Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Loop Health vs Medro

Loop Health
Graded #114

Higher grade

vs+6.399999999999999
Medro
Graded #256

Lower grade

The verdict

Loop Health takes it — 70/100 to 63.6/100.

Loop Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Loop Health is a US telehealth membership platform offering compounded semaglutide and tirzepatide under its Loop Lean program, alongside peptides, NAD+, sermorelin, coaching, and bloodwork.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLoop Health +29
79
50
Dose & formulationMedro +13
64
77
Clinical oversightLoop Health +8
79
71
Labs & monitoringLoop Health +21
73
52
FulfillmentMedro +30
62
92
Contract termsLoop Health +8
41
33
Loop Health · left barMedro · right bar

The numbers

MetricLoop HealthMedro
WeighScore70/10063.6/100
GradeCC
Scorecard rank#114#256
Semaglutide$79/mo (plus a separate fee, compounded)$199/mo (compounded)
Tirzepatide$125/mo (annual plan, plus a separate fee, compounded)$299/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Loop Health

Graded #114 · C

Strengths

  • Multi-product wellness platform — GLP-1 plus peptides, NAD+, coaching, bloodwork
  • Low membership entry point ($79/mo)
  • Annual plan includes monthly 'research credit' toward compounds
  • Explicit compounded-drug FDA disclaimer on-site

Where it loses points

  • Per-dose GLP-1 drug pricing not transparent on public site (compounds billed separately by pharmacy)
  • States-served list not enumerated — only 'select U.S. states'
  • Platform explicitly 'is not a healthcare provider' — relies on independent provider network
  • No LegitScript number disclosed on homepage
Medro

Graded #256 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard